Compile Data Set for Download or QSAR
maximum 50k data
Found 198 with Last Name = 'olszewski' and Initial = 'k'
LigandPNGBDBM453246(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  12nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  26nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  33nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  36nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM453246(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  37nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM453228(US10729691, Example 13)
Affinity DataIC50:  47nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  48nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM50514308(CHEMBL4448899)
Affinity DataIC50:  50nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM453218(US10729691, Example 3)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453221(US10729691, Example 6)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453222(US10729691, Example 7)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453222(US10729691, Example 7)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453227(US10729691, Example 12)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453228(US10729691, Example 13)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453231(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453233(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-1-methy...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453234(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453235(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453236(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[3...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453241(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453242(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453242(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453243(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453243(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453244(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453245(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453246(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453253(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-methy...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453255(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453255(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453256(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453256(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453258(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)thieno[3...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453259(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453260(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453260(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453261(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453261(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453262(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453262(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453263(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453263(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-6-acety...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453264(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPutative sugar transporter(Plasmodium falciparum)
Kadmon

US Patent
LigandPNGBDBM453265(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:Parasite cultures were seeded in 96-well plates (1% hematocrit, 1-2% starting parasitemia, 100 μL total volume) with varying concentrations of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453266(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453267(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-7,8-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453268(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)pyrido[4...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM453217(2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dih...)
Affinity DataIC50:  55nMAssay Description:HT1080 cells (as well as other cell types) were plated to confluency in 96-well plates. Cells were exposed to the combination of 10 μM Oligomyci...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 198 total ) | Next | Last >>
Jump to: